期刊文献+

不稳定型心绞痛患者介入治疗后超敏C反应蛋白与预后的关系 被引量:15

Changes of high sensitivity C-reactive protein of unstable angina pectoris after percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨不稳定型心绞痛(UAP)患者介入治疗后超敏C反应蛋白(hs-CRP)的变化,并评估其对患者预后的影响。方法对符合条件的158例行经皮冠脉介入治疗(PCI)的UAP患者(UAP组)和91例冠状动脉造影正常患者(对照组),采用双抗体夹心法检测术前、术后24h血清hs-CRP的变化;并对UAP患者进行术后1年随访,以评价术后24h血清hs-CRP水平与首次发生主要心血管病事件的关系。结果UAP组术后24h血清hs-CRP浓度与术前的差值高于对照组[(1.08±0.89)mg/L∶(0.36±0.29)mg/L,t=7.483,P=0.000];PCI术后血清hs-CRP≥3.0 mg/L的UAP患者1年内首次主要心血管病事件的发生率高于hs-CRP<3.0 mg/L者(2χ=1.267,P=0.260)。结论PCI术后24h血清hs-CRP水平是影响UAP患者1年内首次发生主要心血管病事件的一个重要因素。 Objective To study the changes of high sensitivity e-reactive protein (hs-CRP) of unstable angina pectoris (UAP) after pereutaneous coronary intervention (PCD and evaluate the affection of hs-CRP for UAP's prognosis. Methods The serum hs-CRP before operation and 24h after operation was detected by sandwich immunodetection method in 158 cases with UAP(UAP group) with PCI and 91 cases with normal coronary arteriongraphy (control group). The relationship was appreciated between the serum levels of hs-CRP 24h after operation and the first time happening major cardiovascular events in follow-up visit of a year. Results The difference of serum levels of hs-CRP with before operation and 24h after operation of UAP patients were higher than the control group. The incidence of first time of major cardio- vascular events of patients with UAP after one year of PCI for UAP group(hs-CRP≥3.0 mg/L)were higher than the control group(hs-CRP 〈3.0 mg/L)(χ^2 =1. 267,P=0. 260). Conclusion The serum levels of hs-CRP of 24h after PCI were the important factor affecting the first time of major cardiovascular events of patients with UAP.
出处 《西部医学》 2010年第1期72-74,共3页 Medical Journal of West China
关键词 不稳定型心绞痛 经皮冠状动脉介入治疗 高敏C反应蛋白 Unstable angina pectoris Pereutaneous coronary intervention High sensitivity c-reactive protein
  • 相关文献

参考文献16

  • 1Ishikawa T;Hatakeyama K;Imamura T.Involvement of Creactive proteinobtained by directional coronary atherectomy in plaque instability and develo-ping restenosis in patients with stable or unstable angina pectoris,2003(03).
  • 2Edward TH;Yeh MD;Hvernon Anderson MD.C-reactive protein linking inflammation to cardiovascular complications,2001(09).
  • 3Dibra A;Mehilli J;Braun S.Inflammatory response after intervention as-sessed by serial C-reactive protein measurements correlates with restenosis in pa-tients treated with coronary senting[J],2005(02).
  • 4Tomoda H;Aoki N.Instablility of coronary lesions in unstable anginaassessed by C-reactive protein values following coronary interventions[J],2001(02).
  • 5Li JJ.Silent myocardial ischemia may be related to inflammatory response[J],2004(02).
  • 6陈军,周颖玲,杨希立,黄文辉,李健民,周昭伦.罗格列酮对2型糖尿病患者冠脉支架内再狭窄的预防作用[J].中国临床药学杂志,2005,14(4):223-225. 被引量:10
  • 7Fischman DL;Leon MB;Baim DS.A randomized comparison of coronary-stent placement and ballon,angiop lasty in treatment of coronary artery disease[J],1994(08).
  • 8不稳定性心绞痛诊断和治疗建议[J].中华心血管病杂志,2000,28(6):409-412. 被引量:2694
  • 9Gach O;Legrand V;Biessaux Y;Chapelle JP.Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris,2007(01).
  • 10Liuzzo G;Buffon A;Biasucci LM.Enhanced inflammatory responseto coronary angioplasty in patients with severe unstable angina[J],1998(22).

二级参考文献6

  • 1Moses JW, Moussa I, Leon MB, et al. Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I randomized trial)[J]. Am J Cardiol, 2002,90(3) :243.
  • 2Fonseca V, Desouza C, Asnani S, et al. Nontraditional risk factors for cardiovascular disease in diabetes[J]. Endocr Rev, 2004 ,25(1): 153.
  • 3Mohanty P, Aljada A,Ghanim H, , et al . Evidence for a potent antiinflammatory effect of rosiglitazone [ J ]. J Clin Endocrinol Metab, 2004,89(6) :272.
  • 4Takagi T, Yamamuro A, Tamita K, et al .Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus:an intravascular ultrasound scanning study [ J ].Am Heart J ,2003, 146(2):E5.
  • 5David R, Martin B, Jeffrey W, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial[J]. Circulation,2004,109(5) :634.
  • 6William J, Kurt G, John M, et al. Rosiglitazone reduces the accelerated neointima after arterial injury in a mouse injury model of type 2 diabetes[J]. Circulation,2003,108(16): 1994.

共引文献2703

同被引文献50

引证文献15

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部